Ganymed Robotics develops advanced robotics technologies for orthopedics, focusing on improving patient outcome, surgeon experience, and overall efficiency of joint replacement interventions.

Ganymed Robotics

There are more and more humans. More and more of them need surgery. Orthopedics especially is driven primarily by age and weight so... yeah. It's going to be impossible to train as many surgeons, let alone good and experienced ones, as the world needs. So what do we do? Let people die of a fractured hip? 

We believe technology holds part of the answer. We believe the success or failure of a surgical intervention shouldn't be a direct result of the surgeon's state of mind. We believe it's possible to create tools that will improve both patient outcome and surgeon experience. We believe it's unacceptable to live in a world where *5 billion* people have no access to surgery whatsoever. 

We develop advanced robotics technologies for orthopedic surgeons. So that more people have access to life-changing orthopedic surgeries, safely and affordably. Freedom starts with movement. And we believe in what we do.

Supported by A-Level entrepreneurs and innovators such as Bruno Maisonnier (Founder of Aldebaran Robotics, Founder & CEO AnotherBrain) and world-class orthopedic surgeons, we work hard to change the status quo in surgery. 

We are incubated at one of Europe's best life science incubator, Paris Biotech Santé (ever heard of DNAScript, Therapenacea and Therapixel ? They are here too). We have raised significant seed money. We have gathered a world-class team. We're all in. We're still hiring.

Bpifrance

European Commission

European Innovation Council

AGORANOV

Kurma Partners

BNP Paribas Développement

Cathay Capital

Crédit Mutuel Innovation

CapHorn Invest

Merci à l'Agence de l'innovation en santé, au Secrétariat général pour l'investissement et #France2030 pour cette feuille de route ambitieuse au service des patients et des praticiens ! 

Nous sommes honorés d'avoir été consultés, et reconnaissants du soutien continu des pouvoirs publics pour l'innovation en santé, et plus particulièrement en robotique chirurgicale. 

L'écosystème français en la matière est exceptionnel, et permet d'aller vers un accès démocratisé à des soins chirurgicaux de pointe combinant le meilleur de l'humain et de la machine.

We have long believed that nimble, low-footprint solutions will succeed better in the fast-growing ASC market for TKA than large, legacy systems. 

For major orthopedics companies to stay relevant, that means securing partnerships with other platforms to offer alternatives to the robots they currently operate. 

It’s now happening, with ZB announcing a distribution agreement with Tmini, a Ct based handheld device. 

The outpatient market is still a blue ocean for computer assisted surgery, and such moves show both its potential - and the inadequacies of existing robots. 

Stay tuned !

https://lnkd.in/gKDA23ks

While in Paris for EuroPCR, one cannot help to breakaway for the genius that exists in medical robotics in this country

Spent time at Ganymed Robotics this afternoon with Silvère Lucquin, Julien Puaux, and Lukas Vancura and hosting us with a behind the scene look at a wonderful platform in the orthopedic market.

Spine surgery is heating up, and computer vision is becoming ubiquitous.

Swiss startup LEM Surgical AG just unveiled its robotic platform for spine surgery, including an embedded vision sensor – which is where the field is going !

This product reveal comes just a few months after its Series B and a few months before its FDA submission - a busy year for LEM Surgical.

Robots are about to take over the OR – this is just the beginning.

🫀 World-first: Caranx Medical successfully performed robotic-assisted heart valve implantation into an animal.

👏🏼 Congratulations Caranx Medical, you are making history with this breakthrough in robotic TAVI - Transcatheter Aortic Valve Implantation.

🏅 Ganymed Robotics is proud to be part of the I-Nov 2023 selection alongside ground-breaking startups.

Something’s definitely happening in the French surgical robotics ecosystem !
Full article 👉🏼 https://lnkd.in/d6Y49_wp

👏🏼 Corin Group has just obtained CE mark approval for its Apollo™ robotic-assisted surgical platform and the ApolloKnee™ software application.
 
The platform strongly resembles the Omni robot, previously Praxiteles, a guide positioning robot for TKA originally invented in France 20 years ago by a prolific team from Grenoble.
 
Will the revamp be enough to convince surgeons and care centers? Watch this space!

👏🏼 Les startups de robotique chirurgicale de nouveau à la une du Monde.

Après le portrait de Bertrand Nahum et l’enquête sur la chirurgie augmentée, voici le portrait de Bertrand Duplat, CEO de Robeauté.

Ganymed Robotics et Robeauté se connaissent bien, pour avoir été d’abord à Agoranov puis à Paris Biotech Santé, deux incubateurs deep tech très sélectifs pour les start-up santé !

🏅C’est tout l’écosystème qui bénéficie de voir ses pépites mises à l’honneur.
Lien vers l’article 👉🏼  https://lnkd.in/eJyFARRN

🧑🏼⚕️ Nothing matters more than understanding our users & the purpose of our work
 
That's why all new Ganymed members go to the operating room as part of their onboarding - and regularly afterwards
 
Here, operating room immersion day for our QARA colleagues, welcome on board Jeneethan JOSEPH & Sharmila RADJASEGARANE !

👋🏻 We have multiple positions open, including V&V Engineer and Finance Manager

Check out our offers and apply 👉 https://lnkd.in/eA2UZuiJ

Want to know more about who we are and what we do ? Watch our videos !

👏🏼 Merci à France Biotech pour cette 21ᵉ édition du Panorama France HealthTech qui permet de gagner en perspective et qui met en lumière les sociétés & institutions contribuant à la souveraineté sanitaire et à la réindustrialisation du pays 🏅
 
Lien vers l'étude 👉🏼 https://lnkd.in/eS9dV9wh

Metric
Company Name	Ganymed Robotics
Symbol
MSH ID	COM:GANYMEDROBOTICS
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Medical Devices and Technology
Country	FR
Stage
Employee Count
Website	ganymedrobotics.com
LinkedIn	ganymed-robotics
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

GANY

COM:GANYMEDROBOTICS

Ganymed Robotics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue